SHANNON LEARY: Open Payments
NPI 1477227338 · GLENDALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 16 payments from 7 companies in 2025. Trend: 2023 $268 · 2024 $267 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $118 |
| Lilly USA, LLC | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Optinose US, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Ozempic, MOUNJARO, BREZTRI, Xhance, ZEPBOUND, PAXLOVID, Cologuard Collection Kit, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
